At Abdul Latif Jameel Health Saudi Arabia, we provide integrated Distribution and In-market Services Solutions to our partners, opening new opportunities to accelerate access to modern health care. We are committed to introducing Innovative Medical Devices and Specialized Pharmaceuticals.
About Abdul Latif Jameel Health Saudi Arabia
Abdul Latif Jameel Health Accelerating Access Adding Value
We strive to accelerate access to unmet medical needs by forging dynamic partnerships and leveraging a robust distribution network, thus adding value to KSA’s healthcare ecosystems
Abdul Latif Jameel Health Saudi Arabia builds on the Jameel family’s long-established philanthropy, Community Jameel, and its focus on innovating for a better future by seeking to solve problems at their source.
This includes the co-founding of the Abdul Latif Jameel Clinic for Machine Learning in Health (Jameel Clinic) at MIT and the Abdul Latif Jameel Institute for Disease & Emergency Analytics (Jameel Institute) at Imperial College London.
With a strong belief, Abdul Latif Jameel inhabits this philosophy through its organic and inorganic growth strategies that are built around introducing innovative medical products, pharmaceuticals, merges and acquisition, Joint ventures, strategy alliances backed up by a robust distribution network and competent regulatory framework thus addressing tangible real-world needs today – for a better tomorrow.
Our Vision
Our vision is to be a leading healthcare company offering innovative pharmaceutical and medical products that enhance the quality of patient’s clinical outcomes within KSA.
Our Mission
Our mission is to accelerate access to unmet medical needs by forging dynamic partnerships and leveraging a robust distribution network, thus adding value to KSA’s healthcare ecosystems.
Our Approach
We strive to accelerate access to unmet medical needs by forging dynamic partnerships and leveraging a robust distribution network, thus adding value to KSA’s healthcare ecosystems
Abdul Latif Jameel Health Saudi Arabia builds on the Jameel family’s long-established philanthropy, Community Jameel, and its focus on innovating for a better future by seeking to solve problems at their source.
This includes the co-founding of the Abdul Latif Jameel Clinic for Machine Learning in Health (Jameel Clinic) at MIT and the Abdul Latif Jameel Institute for Disease & Emergency Analytics (Jameel Institute) at Imperial College London.
With a strong belief, Abdul Latif Jameel inhabits this philosophy through its organic and inorganic growth strategies that are built around introducing innovative medical products, pharmaceuticals, merges and acquisition, Joint ventures, strategy alliances backed up by a robust distribution network and competent regulatory framework thus addressing tangible real-world needs today – for a better tomorrow.
A Message from Chairman
Chairman-Abdul Latif Jameel Enterprises
Faisal S. Alsamannoudi
Harnessing Key Trends as Drivers of Success
Technology adoption
The rapid innovation cycle in global health technology , including AI, robotics, therapeutics, medical devices, regenerative medicine and more, presents significant opportunities.
This is impacting drug and device filing, registration, and market authorization as well as licensing arrangements.
We seek to both invest in emerging ideas and connect businesses to new growth opportunities, particularly in rapidly developing markets across the Global South.
National Health Security
Increasing resilience in our society’s healthcare systems and processes to increase public and private health security has become a pressing need
With our international and local network, we are uniquely positioned to be a key player in this emerging environment helping our partners to deliver and realizing our overarching goal of expanding access and enhancing resilience and business continuity to modern health care.
Localization – Local Partnerships
Tailoring health solutions to local markets is a key pre-requisite for success. Government endorsement and incentives to promote local manufacturing are driving momentum and a rising investment in local manufacturing.
We are continually fostering our network of local partnerships, globally, to develop tangible and sustainable local solutions.
Patient Centricity
Increasing patient centricity worldwide continues to drive the importance of patient education and support programs.
We are ready to play our role in enabling individuals to take an active interest in their own health management.
Patient Centricity
Increasing patient centricity worldwide continues to drive the importance of patient education and support programs.
We are ready to play our role in enabling individuals to take an active interest in their own health management.